Dose Ranging Study of a Drug for the Treatment of Acute Migraine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01430442
Recruitment Status : Completed
First Posted : September 8, 2011
Last Update Posted : February 21, 2018
Information provided by (Responsible Party):
Biohaven Pharmaceutical Holding Company Ltd.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2012
  Actual Study Completion Date : May 2012
  Certification/Extension First Submitted : September 23, 2015